Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LGND

Ligand Pharmaceuticals Inc

May 07 • 02:02PM ET

210.02

-22.53 -9.69 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: HALO EXEL VKTX ALKS MDGL

| Held by: IJR VTI IWM VB VBR VXF SPSM IJT XSMO IWN

Scroll to Statements

Index	RUT	P/E	35.99	EPS (ttm)	5.83	Insider Own	2.58%	Shs Outstand	19.77M	Perf Week	-8.47%
Market Cap	4.21B	Forward P/E	18.95	EPS next Y	11.08	Insider Trans	-9.07%	Shs Float	19.52M	Perf Month	0.93%
Enterprise Value	3.93B	PEG	1.28	EPS next Q	2.00	Inst Own	103.72%	Short Float	7.21%	Perf Quarter	9.56%
Income	124.45M	P/S	15.70	EPS this Y	10.52%	Inst Trans	0.28%	Short Ratio	6.39	Perf Half Y	10.86%
Sales	268.09M	P/B	4.08	EPS next Y	23.33%	ROA	9.95%	Short Interest	1.41M	Perf YTD	11.08%
Book/sh	51.44	P/C	5.74	EPS next 5Y	14.81%	ROE	13.47%	52W High	247.38 -15.10%	Perf Year	98.84%
Cash/sh	36.61	P/FCF	86.04	EPS past 3/5Y	- -	ROIC	8.48%	52W Low	98.89 112.38%	Perf 3Y	164.74%
Dividend Est.	-	EV/EBITDA	47.67	Sales past 3/5Y	10.96% 7.54%	Gross Margin	82.37%	Volatility	3.47% 4.23%	Perf 5Y	149.17%
Dividend TTM	-	EV/Sales	14.65	EPS Y/Y TTM	12825.45%	Oper. Margin	17.61%	ATR (14)	10.95	Perf 10Y	173.12%
Dividend Ex-Date	Jul 02, 2010	Quick Ratio	21.98	Sales Y/Y TTM	60.40%	Profit Margin	46.42%	RSI (14)	41.85	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	22.23	EPS Q/Q	229.31%	SMA20	-7.38%	Beta	1.22	Target Price	267.33
Payout	0.00%	Debt/Eq	0.44	Sales Q/Q	39.37%	SMA50	-1.61%	Rel Volume	2.27	Prev Close	232.55
Employees	47	LT Debt/Eq	0.44	Earnings	May 07 BMO	SMA200	11.22%	Avg Volume	220.17K	Price	210.02
IPO	Nov 18, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	-10.23% -11.88%	Trades		Volume	356,797	Change	-9.69%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)